聚多巴胺纳米材料用于克服癌症治疗当前的挑战
Shahinur Acter1, Michele Moreau1, Robert Ivkov1
1Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.
Nanomaterials (Basel, Switzerland)
|May 27, 2023
概括
聚多巴胺 (PDA) 纳米颗粒由于其生物相容性和药物载荷能力,对癌症治疗有希望. 这一综述强调了PDA的重点.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 多功能纳米粒子对于推进癌症治疗至关重要.
- 聚多巴胺 (PDA) 是一种生物灵感的聚合物,具有独特的优势,如生物相容性,生物降解性和优异的药物载荷.
- PDA固有的特性,包括光热转换和粘附,使其成为纳米医学的多功能平台.
研究的目的:
- 对用于癌症治疗的聚多巴胺 (PDA) 纳米粒子进行现有研究进行审查.
- 探索PDA在开发用于创新的癌症治疗策略的多功能纳米材料方面的潜力.
- 介绍PDA在增强放射治疗,免疫治疗和图像引导药物递送方面的未来前景.
主要方法:
- 对聚多巴胺 (PDA) 纳米粒子研究的文献综述.
- 对PDA与癌症治疗应用相关的特性进行分析.
- 检查PDA在光热疗法,放射疗法,免疫疗法和药物输送中的潜力.
主要成果:
- PDA纳米颗粒显示出药物加载和光热转换的巨大潜力.
- PDA的可调节特性允许工程形态和尺寸,促进功能化.
- 研究表明PDA在开发用于癌症治疗的多功能纳米材料方面的有效性.
结论:
- 聚多巴胺 (PDA) 是一种非常有前途的材料,用于在瘤学中制造先进的多功能纳米材料.
- 基于PDA的纳米材料为增强光热疗法,放射疗法和免疫疗法提供了潜力.
- 未来的应用包括图像引导的药物输送,以提高治疗效率和减少副作用.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


